A systematic review of the characteristics of adolescents with major depressive disorder in randomised controlled treatment trials

被引:1
作者
McCulloch, Amy [1 ,2 ]
Kroll, Leo [1 ]
Glass, James [3 ]
Dubicka, Bernadka [1 ,4 ]
机构
[1] Pennine Care NHS Fdn Trust Headquarters, Young Peoples Mental Hlth Res Unit, 225 Old St, Ashton Under Lyne OL6 75R, Lancs, England
[2] Northwest Boroughs Healthcare NHS Fdn Trust, Warrington CAMHS, 12 Birch Ave, Winwick WA2 9TN, England
[3] Pennine Care NHS Fdn Trust, Springleigh Clin, Hlth Young Minds Tameside & Glossop, Waterloo Rd, Stalybridge SK15 2AU, England
[4] Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PL, Lancs, England
关键词
Adolescent; Depression; Antidepressant; Psychological therapy; Randomised controlled trial; COGNITIVE-BEHAVIORAL THERAPY; ANTIDEPRESSANT EFFICACY TRIALS; EXCLUSION CRITERIA; RISK-FACTORS; PSYCHOTHERAPY; COMORBIDITY; CHILDHOOD; COMMUNITY; CHILDREN; IMPACT;
D O I
10.1016/j.ejpsy.2021.07.001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background and Objectives: Concerns exist around the generalizability of randomised controlled trials (RCTs) for adolescents with major depressive disorder (MDD). This review assesses whether adolescents with MDD treated in RCTs are representative of clinical samples. Methods: A systematic narrative review of selection criteria used in RCTs for adolescent MDD (PROSPERO CRD42018096298). Included were studies assessing psychological, pharmacological or combination treatments. Results: 52 studies were included. Overall, the reporting of selection criteria (defined as both inclusion and exclusion criteria), in the 23 psychotherapy trials was low (52% did not report on comorbid emotional disorders and 48% did not report on suicidal ideation). In contrast, the majority of selection criteria were reported in the 22 medication trials and the 7 combination trials. Where selection criteria were reported, most adolescents with comorbidities were excluded from psychotherapy and medication trials. The 7 combination trials included more adolescents with comorbidities. Of note, only 10 of the 52 studies reported on self-harm as a selection criteria. Conclusion: Reporting of the characteristics of depressed adolescents was poor in psychotherapy trials. Both psychotherapy and medication trials excluded many adolescents with co-morbid conditions, however combination trials tended to be more inclusive. There is concern that many RCTs for adolescent MDD may not be generalizable to clinical populations, particularly with regards to comorbidity, self-harm and suicidal ideation. The findings suggest that clinicians need to view the evidence base and guidelines developed from RCTs with discernment. Pragmatic trials are needed with representative clinical populations and comprehensive reporting of the selection criteria. (C) 2021 Asociacion Universitaria de Zaragoza para el Progreso de la Psiquiatria y la Salud Mental. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [31] Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review
    Khorassani F.
    Jermain M.
    Cadiz C.
    Current Treatment Options in Psychiatry, 2024, 11 (2) : 123 - 140
  • [32] The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
    Chuyuan Miao
    Yun Gao
    Xiaohua Li
    Ying Zhou
    Joanne Wai-yee Chung
    Graeme D. Smith
    BMC Complementary Medicine and Therapies, 23
  • [33] Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials
    Apler, Alex
    BMJ OPEN, 2011, 1 (02):
  • [34] The research gap in chronic paediatric pain: A systematic review of randomised controlled trials
    Boulkedid, R.
    Abdou, A. Y.
    Desselas, E.
    Monegat, M.
    de Leeuw, T. G.
    Avez-Couturier, J.
    Dugue, S.
    Mareau, C.
    Charron, B.
    Alberti, C.
    Kaguelidou, F.
    EUROPEAN JOURNAL OF PAIN, 2018, 22 (02) : 261 - 271
  • [35] Doubly blind: a systematic review of gender in randomised controlled trials
    Phillips, Susan P.
    Hamberg, Katarina
    GLOBAL HEALTH ACTION, 2016, 9 : 1 - 18
  • [36] Placebo Response in Randomized Controlled Trials of Antidepressants for Pediatric Major Depressive Disorder
    Bridge, Jeffrey A.
    Birmaher, Boris
    Iyengar, Satish
    Barbe, Remy P.
    Brent, David A.
    AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (01) : 42 - 49
  • [37] Neuropsychological functioning in adolescents and young adults with major depressive disorder - A review
    Baune, Bernhard T.
    Fuhr, Margarete
    Air, Tracy
    Hering, Carola
    PSYCHIATRY RESEARCH, 2014, 218 (03) : 261 - 271
  • [38] Exercise as an add-on strategy for the treatment of major depressive disorder: a systematic review
    Mura, Gioia
    Moro, Maria Francesca
    Patten, Scott B.
    Carta, Mauro G.
    CNS SPECTRUMS, 2014, 19 (06) : 496 - 508
  • [39] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [40] Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults- A Systematic Review
    Watford, Tessa
    Masood, Naqash
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (01) : 2 - 12